Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery

Aims To determine if treatment with sitagliptin, a dipeptidyl peptidase-4 inhibitor, can prevent stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.Methods We conducted a pilot, double-blinded, placebo-controlled randomized trial in adults (18–80...

Full description

Bibliographic Details

Published in:	BMJ Open Diabetes Research & Care
Main Authors:	Saumeth Cardona, Priyathama Vellanki, Maya Fayfman, Rodolfo J Galindo, Francisco J Pasquel, Katerina Tsegka, Limin Peng, Sol Jacobs, Michael Halkos, Robert A Guyton, Vinod H Thourani, Guillermo Umpierrez
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2019-05-01
Online Access:	https://drc.bmj.com/content/7/1/e000703.full